litlas
ログインアカウント作成

Paresh Vyas

1992–2025 年に発表

139
論文数
27,698
被引用数
82
h 指数
136
i10 指数

被引用数

Paresh Vyas の年別被引用数1990 年: 被引用 1 件1993 年: 被引用 4 件1994 年: 被引用 3 件1995 年: 被引用 2 件1996 年: 被引用 8 件1997 年: 被引用 20 件1998 年: 被引用 25 件1999 年: 被引用 21 件2000 年: 被引用 22 件2001 年: 被引用 33 件2002 年: 被引用 30 件2003 年: 被引用 43 件2004 年: 被引用 32 件2005 年: 被引用 57 件2006 年: 被引用 50 件2007 年: 被引用 64 件2008 年: 被引用 70 件2009 年: 被引用 77 件2010 年: 被引用 59 件2011 年: 被引用 77 件2012 年: 被引用 149 件2013 年: 被引用 151 件2014 年: 被引用 193 件2015 年: 被引用 226 件2016 年: 被引用 260 件2017 年: 被引用 253 件2018 年: 被引用 296 件2019 年: 被引用 1,043 件2020 年: 被引用 1,146 件2021 年: 被引用 1,323 件2022 年: 被引用 1,003 件2023 年: 被引用 913 件2024 年: 被引用 1,416 件2025 年: 被引用 672 件2026 年: 被引用 11 件1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,408 件、この内訳の 27%イギリス: 引用元論文 1,082 件、この内訳の 8.6%ドイツ: 引用元論文 957 件、この内訳の 7.6%中国: 引用元論文 821 件、この内訳の 6.5%イタリア: 引用元論文 754 件、この内訳の 6%フランス: 引用元論文 610 件、この内訳の 4.8%スペイン: 引用元論文 427 件、この内訳の 3.4%カナダ: 引用元論文 422 件、この内訳の 3.4%オランダ: 引用元論文 384 件、この内訳の 3%オーストラリア: 引用元論文 349 件、この内訳の 2.8%日本: 引用元論文 321 件、この内訳の 2.5%スイス: 引用元論文 248 件、この内訳の 2%
0%27%その他 22.4%

機関

分野

  • Medicine63.6%
  • Biochemistry, Genetics and Molecular Biology28.2%
  • Immunology and Microbiology6.2%
  • Neuroscience0.5%
  • Computer Science0.3%
  • Chemistry0.3%
  • その他0.9%

トピック

  • Acute Myeloid Leukemia Research15.4%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.3%
  • Hematopoietic Stem Cell Transplantation3.8%
  • Epigenetics and DNA Methylation3.5%
  • Cancer Genomics and Diagnostics3.4%
  • Acute Lymphoblastic Leukemia research3%
  • その他66.6%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    著者: Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz, Jessica K. Altman, Richard M. Stone, Daniel J. DeAngelo, Ross L. Levine, Ian W. Flinn, Hagop M. Kantarjian, Robert H. Collins, Manish R. Patel, Arthur E. Frankel, Anthony S. Stein, Mikkael A. Sekeres, Ronan Swords, Bruno C. Medeiros, Christophe Willekens, Paresh Vyas, Alessandra Tosolini, Qiang Xu, Robert Knight, Katharine Yen, Sam Agresta, Stéphane de Botton, Martin S. Tallman - Blood 2017 被引用: 1,469

  3. Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

    著者: Gerrit Jan Schuurhuis, Michael Heuser, Sylvie Freeman, Marie C. Béné, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K. Hills, Christopher S. Hourigan, Jeffrey L. Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A. van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L. Wood, Roland B. Walter, Konstanze Döhner, Gail J. Roboz, Gert J. Ossenkoppele - Blood 2018 被引用: 1,029

  4. Clinical and biological implications of driver mutations in myelodysplastic syndromes

    著者: Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Sung-Soo Yoon, Peter Ellis, David C. Wedge, Andrea Pellagatti, Adam Shlien, Michael J. Groves, Simon Forbes, Keiran Raine, Jon Hinton, Laura Mudie, Stuart McLaren, Claire Hardy, Calli Latimer, Matteo Giovanni Della Porta, Sarah O’Meara, Ilaria Ambaglio, Anna Gallì, Adam P. Butler, Gunilla Walldin, Jon W. Teague, Lynn Quek, Alex Sternberg, Carlo Gambacorti‐Passerini, Nicholas C.P. Cross, Anthony R. Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellström‐Lindberg, David Bowen, Mario Cazzola, Michael R. Stratton, Peter J. Campbell - Blood 2013 被引用: 1,832

  5. Assessment of Minimal Residual Disease in Standard-Risk AML

    著者: Adam Ivey, Robert K. Hills, Michael A. Simpson, Jelena Jovanović, Amanda Gilkes, Angela Grech, Yashma Patel, Neesa Bhudia, Hassan Farah, Joanne Mason, Kerry Wall, Susanna Akiki, Mike Griffiths, Ellen Solomon, Frank McCaughan, David C. Linch, Rosemary E. Gale, Paresh Vyas, Sylvie Freeman, Nigel H. Russell, Alan K. Burnett, David Grimwade - New England Journal of Medicine 2016 被引用: 836

  6. Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study

    著者: David A. Sallman, Monzr M. Al Malki, Adam S. Asch, Eunice S. Wang, Joseph G. Jurcic, Terrence Bradley, Ian W. Flinn, Daniel A. Pollyea, Suman Kambhampati, Tiffany Tanaka, Joshua F. Zeidner, Guillermo Garcia‐Manero, Deepa Jeyakumar, Rami S. Komrokji, Jeffrey E. Lancet, Hagop M. Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark P. Chao, Carol O’Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval Daver - Journal of Clinical Oncology 2023 被引用: 171

  7. Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

    著者: Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti, Guillermo Garcia‐Manero, Rena Buckstein, Valeria Santini, María Díez‐Campelo, Carlo Finelli, Mario Cazzola, Osman İlhan, Mikkael A. Sekeres, José Falantes, Beatriz Arrizabalaga, Flavia Salvi, Valentina Giai, Paresh Vyas, David Bowen, Dominik Selleslag, Amy E. DeZern, Joseph G. Jurcic, Ulrich Germing, Katharina S. Götze, Bruno Quesnel, Odile Beyne‐Rauzy, Thomas Cluzeau, Maria-Teresa Voso, Dominiek Mazure, Edo Vellenga, Peter L. Greenberg, Eva Hellström-Lindberg, Amer M. Zeidan, Lionel Adès, Amit Verma, Michael R. Savona, Abderrahmane Laadem, Aziz Benzohra, Jennie Zhang, Anita Rampersad, Diana Dunshee, Peter G. Linde, Matthew L. Sherman, Rami S. Komrokji, Alan F. List - New England Journal of Medicine 2020 被引用: 537

  8. SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts

    著者: Elli Papaemmanuil, Mario Cazzola, Jacqueline Boultwood, Luca Malcovati, Paresh Vyas, David Bowen, Andrea Pellagatti, James S. Wainscoat, Eva Hellström‐Lindberg, Carlo Gambacorti‐Passerini, Anna L. Godfrey, Inmaculada Rapado, Ana Cvejic, Richard Rance, Chris McGee, Peter Ellis, Laura Mudie, Philip J. Stephens, Stuart McLaren, Charles Massie, Patrick Tarpey, Ignacio Varela, Serena Nik‐Zainal, Helen Davies, Adam Shlien, David Jones, Keiran Raine, Jonathan Hinton, Adam P. Butler, Jon W. Teague, E. Joanna Baxter, J Score, Anna Gallì, Matteo Giovanni Della Porta, Erica Travaglino, Michael J. Groves, Sudhir Tauro, Nikhil C. Munshi, Kristina Anderson, Adel K. El‐Naggar, Andrej Fischer, Ville Mustonen, Alan J. Warren, Nicholas C.P. Cross, Anthony R. Green, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell - New England Journal of Medicine 2011 被引用: 1,216

  9. A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1 -Mutated Myeloid Malignancies

    著者: Curtis A. Lachowiez, Sanam Loghavi, Zhihong Zeng, Tomoyuki Tanaka, Yi June Kim, Hidetaka Uryu, Sven Turkalj, Niels Asger Jakobsen, Marlise R. Luskin, Dzifa Y. Duose, Rebecca S. Tidwell, Nicholas J. Short, Gautam Borthakur, Tapan M. Kadia, Lucia Masárová, George D. Tippett, Prithviraj Bose, Elias Jabbour, Farhad Ravandi, Naval Daver, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Jacqueline S. Garcia, Paresh Vyas, Koichi Takahashi, Marina Konopleva, Courtney D. DiNardo - Blood Cancer Discovery 2023 被引用: 122

  10. Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results

    著者: Naval Daver, Paresh Vyas, Suman Kambhampati, Monzr M. Al Malki, Richard A. Larson, Adam S. Asch, Gabriel N. Mannis, Wanxing Chai‐Ho, Tiffany Tanaka, Terrence Bradley, Deepa Jeyakumar, Eunice S. Wang, Kendra Sweet, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Rami S. Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F. Zeidner, David A. Sallman - Journal of Clinical Oncology 2023 被引用: 121

  11. Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

    著者: Young Seok Ju, Ludmil B. Alexandrov, Moritz Gerstung, Sancha Martin, Serena Nik-Zainal, Manasa Ramakrishna, Helen Davies, Elli Papaemmanuil, Gunes Gundem, Adam Shlien, Niccolò Bolli, Sam Behjati, Patrick Tarpey, Jyoti Nangalia, Charles Massie, Adam P. Butler, Jon W. Teague, George S. Vassiliou, Anthony R. Green, Ming‐Qing Du, Ashwin Unnikrishnan, John E. Pimanda, Bin Tean Teh, Nikhil C. Munshi, Mel Greaves, Paresh Vyas, Adel K. El‐Naggar, Tom Santarius, V. Peter Collins, Richard G. Grundy, Jack A. Taylor, D Neil Hayes, David Malkin, ICGC Breast Cancer Group, ICGC Chronic Myeloid Disorders Group, ICGC Prostate Cancer Group, Christopher S. Foster, Anne Y. Warren, Hayley C. Whitaker, Daniel S. Brewer, Rosalind A. Eeles, Colin Cooper, David E. Neal, Tapio Visakorpi, William B. Isaacs, G. Steven Bova, Adrienne M. Flanagan, P. Andrew Futreal, Andy G. Lynch, Patrick F. Chinnery, Ultan McDermott, Michael R. Stratton, Peter J. Campbell - eLife 2014 被引用: 500

  12. Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

    著者: Michael Andreeff, Kevin R. Kelly, Karen Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David Bowen, Giovanni Martinelli, Mark W. Drummond, Paresh Vyas, Mark Kirschbaum, Swaminathan P. Iyer, Vivian Ruvolo, Graciela M. Nogueras‐González, Xuelin Huang, Gong Chen, Bradford Graves, Steven Blotner, Peter J. Bridge, Lori Jukofsky, Steve Middleton, Monica Reckner, Ruediger Rueger, Jianguo Zhi, Gwen Nichols, Kensuke Kojima - Clinical Cancer Research 2015 被引用: 353

  13. Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial

    著者: Courtney D. DiNardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew H. Wei, Stéphane de Botton, Amer M. Zeidan, Amir T. Fathi, Hagop M. Kantarjian, John M. Bennett, Mark G. Frattini, Patricia Martin‐Regueira, Frederik Lersch, Jing Gong, Maroof Hasan, Paresh Vyas, Hartmut Döhner - The Lancet Oncology 2021 被引用: 191

  14. Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

    著者: Francis Mussai, Carmela De Santo, Issa Abu‐Dayyeh, Sarah Booth, Lynn Quek, Rosanna M. McEwen-Smith, Amrana Qureshi, Francesco Dazzi, Paresh Vyas, Vincenzo Cerundolo - Blood 2013 被引用: 324

  15. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS

    著者: Luca Malcovati, Kristen E. Stevenson, Elli Papaemmanuil, Donna Neuberg, Rafael Bejar, Jacqueline Boultwood, David Bowen, Peter J. Campbell, Benjamin L. Ebert, Pierre Fenaux, Torsten Haferlach, Michael Heuser, Joop H. Jansen, Rami S. Komrokji, Jaroslaw P. Maciejewski, Matthew J. Walter, Michaëla Fontenay, Guillermo Garcia‐Manero, Timothy A. Graubert, Aly Karsan, Manja Meggendorfer, Andrea Pellagatti, David A. Sallman, Michael R. Savona, Mikkael A. Sekeres, David P. Steensma, Sudhir Tauro, Felicitas Thol, Paresh Vyas, Arjan A. van de Loosdrecht, Detlef Haase, Heinz Tüchler, Peter L. Greenberg, Seishi Ogawa, Eva Hellström‐Lindberg, Mario Cazzola - Blood 2020 被引用: 293

  16. TP53 -Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions

    著者: Naval Daver, Abhishek Maiti, Tapan M. Kadia, Paresh Vyas, Ravindra Majeti, Andrew H. Wei, Guillermo Garcia‐Manero, Charles Craddock, David A. Sallman, Hagop M. Kantarjian - Cancer Discovery 2022 被引用: 150

  17. Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia

    著者: Alice Giustacchini, Supat Thongjuea, Nikolaos Barkas, Petter Woll, Benjamin Povinelli, Christopher A.G. Booth, Paul Sopp, Ruggiero Norfo, Alba Rodríguez-Meira, Neil Ashley, Lauren E. Jamieson, Paresh Vyas, Kristina Anderson, Åsa Segerstolpe, Hong Qian, Ulla Olsson‐Strömberg, Satu Mustjoki, Rickard Sandberg, Sten Eirik W. Jacobsen, Adam J. Mead - Nature Medicine 2017 被引用: 421

  18. Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

    著者: Nicolas Goardon, Emanuele Marchi, Ann Atzberger, Lynn Quek, Anna Schuh, Shamit Soneji, Petter Woll, Adam J. Mead, Kate A. Alford, Raj Rout, Salma Chaudhury, Amanda Gilkes, Steven Knapper, Kheïra Beldjord, Suriya Begum, Susan R. Rose, Nicola Geddes, Mike Griffiths, Graham R. Standen, Alexander Sternberg, Jamie Cavenagh, Hannah Hunter, David Bowen, Sally Killick, Lisa A. Robinson, Andrew Price, Elizabeth Macintyre, Paul Virgo, Alan Burnett, Charles Craddock, Tariq Enver, Sten Eirik W. Jacobsen, Catherine Porcher, Paresh Vyas - Cancer Cell 2011 被引用: 640

  19. A First-in-Human Phase 1 Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in Adult Patients with Relapsed/Refractory Acute Leukemia Harboring KMT2A or NPM1 Alterations

    著者: Elias Jabbour, Emma Searle, Maher Abdul‐Hay, Sameem Abedin, Ibrahim Aldoss, Ana Alfonso Piérola, Juan Manuel Alonso‐Domínguez, Patrice Chevallier, Carrye Cost, Nikki Daskalakis, Richard Dillon, Neil Dunavin, Jordi Esteve, Amir T. Fathi, Pasquale L. Fedele, Lucille Ferrante, Sylvain Garciaz, Christina Guttke, Emmanuel Gyan, Brett Hiebert, Min Chul Kwon, Jonathan Miller, Teng Fong Ng, Kathryn Packman, Ulrike Philippar, Arnaud Pigneux, Christian Récher, Olga Salamero, Madhu Sanga, Richard M. Stone, Peter Tan, Jan Willem Thuring, Trevor Tucker, Paresh Vyas - Blood 2023 被引用: 49

  20. Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

    著者: Charles Craddock, Aimee Jackson, Justin Loke, Shamyla Siddique, Andrea Hodgkinson, John Mason, Georgia Andrew, Sandeep Nagra, Ram Malladi, Andrew Peniket, Maria Gilleece, Rahuman Salim, Eleni Tholouli, Victoria Potter, Charles Crawley, Keith Wheatley, Rachel Protheroe, Paresh Vyas, Ann Hunter, Anne Parker, Keith Wilson, Jiří Pavlů, Jenny Byrne, Richard Dillon, Naeem Khan, Nicholas McCarthy, Sylvie Freeman - Journal of Clinical Oncology 2020 被引用: 165

  21. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial

    著者: Stéphane de Botton, Pau Montesinos, Andre C. Schuh, Cristina Papayannidis, Paresh Vyas, Andrew H. Wei, Hans Beier Ommen, С. В. Семочкин, Hee‐Je Kim, Richard A. Larson, Jaime Koprivnikar, Olga Frankfurt, Felicitas Thol, Jörg Chromik, Jenny Byrne, Arnaud Pigneux, Xavier Thomas, Olga Salamero, María‐Belén Vídriales, Vadim Doronin, Hartmut Döhner, Amir T. Fathi, Eric Laille, Xin Yu, Maroof Hasan, Patricia Martin‐Regueira, Courtney D. DiNardo - Blood 2022 被引用: 115

  22. Multiple cereblon genetic changes are associated with acquired resistance to lenalidomide or pomalidomide in multiple myeloma

    著者: Sarah Gooding, Naser Ansari‐Pour, Fadi Towfic, María Ortiz Estévez, Philip P. Chamberlain, Kao-Tai Tsai, Erin Flynt, Marissa B. Hirst, Dan Rozelle, Paula Dhiman, Paola Neri, Karthik Ramasamy, Nizar J. Bahlis, Paresh Vyas, Anjan Thakurta - Blood 2020 被引用: 159

  23. Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging

    著者: Niels Asger Jakobsen, Sven Turkalj, Andy G.X. Zeng, Bilyana Stoilova, Marlen Metzner, Susann Rahmig, Murtaza S. Nagree, Sayyam Shah, Rachel Moore, Batchimeg Usukhbayar, Mirian Angulo Salazar, Grigore Gafencu, Alison Kennedy, Simon Newman, Benjamin Kendrick, Adrian Taylor, Rasheed Afinowi-Luitz, Roger Gundle, Bridget Watkins, Kim Wheway, Debra Beazley, Alex Murison, Alicia G. Aguilar-Navarro, Eugenia Flores‐Figueroa, Stephanie G. Dakin, Andrew Carr, Claus Nerlov, John E. Dick, Stephanie Z. Xie, Paresh Vyas - Cell stem cell 2024 被引用: 98

  24. TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups

    著者: Detlef Haase, Kristen E. Stevenson, Donna Neuberg, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, Benjamin L. Ebert, Guillermo Garcia‐Manero, Claudia Haferlach, Torsten Haferlach, Wolfgang Kern, Seishi Ogawa, Yasunobu Nagata, Kenichi Yoshida, Timothy A. Graubert, Matthew J. Walter, Alan F. List, Rami S. Komrokji, Eric Padron, David A. Sallman, Elli Papaemmanuil, Peter J. Campbell, Michael R. Savona, Adam C. Seegmiller, Lionel Adès, Pierre Fenaux, Lee‐Yung Shih, David Bowen, Michael J. Groves, Sudhir Tauro, Michaëla Fontenay, Olivier Kosmider, Michal Bar‐Natan, David P. Steensma, Richard M. Stone, Michael Heuser, Felicitas Thol, Mario Cazzola, Luca Malcovati, Aly Karsan, Christina Ganster, Eva Hellström‐Lindberg, Jacqueline Boultwood, Andrea Pellagatti, Valeria Santini, Lynn Quek, Paresh Vyas, Heinz Tüchler, Peter L. Greenberg, Rafael Bejar - Leukemia 2019 被引用: 259